Cxcr3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Cxcr3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CXCR3 is a G protein-coupled receptor that binds interferon-inducible chemokines (CXCL9, CXCL10, CXCL11). It is expressed on various immune cells including T lymphocytes, NK cells, and [microglia](/cell-types/microglia-neuroinflammation). CXCR3-mediated signaling plays important roles in neuroinflammation and is implicated in the pathogenesis of multiple neurodegenerative diseases.
Function
CXCR3 is a chemokine receptor that plays critical roles in immune cell trafficking and signaling:
Ligand Binding
CXCR3 binds to three primary ligands:
CXCL9 (MIG): IFN-γ-inducible monokine
CXCL10 (IP-10): IFN-γ-inducible protein 10
CXCL11 (I-TAC): IFN-inducible T cell attractant
Signaling Pathways
Upon ligand binding, CXCR3 activates:
Gαi-mediated PI3K/Akt pathway: Cell survival and migration
MAPK pathways: ERK1/2 activation
JAK/STAT signaling: Gene transcription
Disease Associations
Multiple Sclerosis
CXCR3 is highly expressed on Th1 cells and is involved in T cell recruitment to the CNS in MS. CXCL10/CXCR3 signaling drives inflammatory cell infiltration and demyelination. CXCR3 antagonists are being investigated as MS therapies.
Alzheimer's Disease
CXCR3 and its ligands are upregulated in AD brain:
CXCL10 is elevated in AD [hippocampus](/brain-regions/hippocampus) and associated with cognitive decline
CXCR3+ T cells accumulate in AD brain
May contribute to chronic neuroinflammation
Parkinson's Disease
CXCR3-mediated inflammation contributes to dopaminergic neuron loss:
CXCL10 is elevated in PD substantia nigra
CXCR3+ immune cells infiltrate the PD brain
Blocking CXCR3 signaling is protective in PD models
ALS
CXCR3 is implicated in motor neuron disease:
CXCR3+ T cells are found in ALS spinal cord
CXCL10 levels correlate with disease progression
CXCR3 may mediate inflammatory damage to motor [neurons](/entities/neurons)
Expression
CXCR3 is expressed on:
Activated T lymphocytes (especially Th1)
NK cells
Microglia (upregulated in disease states)
Some neurons (pathological conditions)
Endothelial cells
In the brain, CXCR3 expression increases on microglia and infiltrating immune cells during neuroinflammation.
Key Publications
[CXCR3 in multiple sclerosis (2010)](https://doi.org/10.1016/j.tins.2010.01.007)
[CXCR3 chemokines in Alzheimer's disease (2012)](https://doi.org/10.1016/j.neurobiolaging.2011.02.013)
[CXCR3 in Parkinson's disease neuroinflammation (2015)](https://doi.org/10.1016/j.neuropharm.2015.02.005)
The study of Cxcr3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data